Ash Shehata from KPMG discusses how investors are feeling about the pharma and life sciences industry heading into 2025. Pharmaceutical Executive: What’s causing the increase in M&A in 2025? Ash ...
To strengthen the clinical research at KI SÖS we have broadened ongoing projects by networking with other groups at Karolinska Institutet, as well as national and international external departments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback